Swedish Orphan Biovitrum AB (publ) banner

Swedish Orphan Biovitrum AB (publ)
OTC:SWOBY

Watchlist Manager
Swedish Orphan Biovitrum AB (publ) Logo
Swedish Orphan Biovitrum AB (publ)
OTC:SWOBY
Watchlist
Price: 25 USD Market Closed
Market Cap: $17.1B

Wall St Price Targets

SWOBY Price Targets Summary
Swedish Orphan Biovitrum AB (publ)

Wall Street analysts forecast SWOBY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SWOBY is 25.02 USD with a low forecast of 16.59 USD and a high forecast of 30.8 USD.

Lowest Forecast
Price Target
16.59 USD
34% Downside
Average Forecast
Price Target
25.02 USD
0% Upside
Highest Forecast
Price Target
30.8 USD
23% Upside
Swedish Orphan Biovitrum AB (publ) Competitors:
Price Targets
QXO
SilverSun Technologies Inc
128% Upside
FLEX
Flex Ltd
31% Upside
ULTA
Ulta Beauty Inc
30% Upside

Revenue
Forecast

23% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
23% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 23%. The projected CAGR for the next 8 years is 9%.

Gross Profit
Forecast

27% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
27% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 27%. The projected CAGR for the next 8 years is 9%.

Operating Income
Forecast

N/A
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
4%
Average Beat
N/A
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
4%
Average Beat

The compound annual growth rate for Operating Income over the next 8 years is 9%.

Pre-Tax Income
Forecast

N/A
Past Growth
600% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
600% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

The compound annual growth rate for Pre-Tax Income over the next 3 years is 600%.

Net Income
Forecast

N/A
Past Growth
43% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat
N/A
Past Growth
43% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat

The compound annual growth rate for Net Income over the next 8 years is 43%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is SWOBY's stock price target?
Price Target
25.02 USD

According to Wall Street analysts, the average 1-year price target for SWOBY is 25.02 USD with a low forecast of 16.59 USD and a high forecast of 30.8 USD.

What is the Revenue forecast for Swedish Orphan Biovitrum AB (publ)?
Projected CAGR
9%

Over the last 13 years, the compound annual growth rate for Revenue has been 23%. The projected CAGR for the next 8 years is 9%.

What is the Gross Profit forecast for Swedish Orphan Biovitrum AB (publ)?
Projected CAGR
9%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 27%. The projected CAGR for the next 8 years is 9%.

What is the Operating Income forecast for Swedish Orphan Biovitrum AB (publ)?
Projected CAGR
9%

The compound annual growth rate for Operating Income over the next 8 years is 9%.

What is the Pre-Tax Income forecast for Swedish Orphan Biovitrum AB (publ)?
Projected CAGR
600%

The compound annual growth rate for Pre-Tax Income over the next 3 years is 600%.

What is the Net Income forecast for Swedish Orphan Biovitrum AB (publ)?
Projected CAGR
43%

The compound annual growth rate for Net Income over the next 8 years is 43%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett